Study of Efficacy and Safety of GNR-060 vs Metalyse in Patients With ST Elevation Myocardial Infarction

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 244 participants.

Also called NCT05601999

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 244 participants (enrolled count) (from the registry)
Sponsor
  • AO GENERIUM Registry lists this organization as the lead sponsor
Registry
  • NCT NCT05601999
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Russia (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05601999. Randomized; double masking; primary purpose treatment. Start 2021-09-03 (actual); primary completion 2024-05-06 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Study of Efficacy and Safety of GNR-060 vs Metalyse in Patients With ST Elevation Myocardial Infarction
Condition
ST Elevation Myocardial Infarction
Intervention (Biological)
GNR-060
Intervention (Biological)
Metalyse
Lead sponsor
AO GENERIUM (class: industry)

Record details

Record id
cardio:ct-nct05601999
Content hash
2c64665f98b65859f7b9ad348819aeb82d0a0042987e301cf53723207a18ec79